Dell was recently named the winner of the 2008 Life Sciences Industry Award for Best in Class Hardware Supplier. The award is voted on by life sciences companies and awarded by The Scientist magazine and BioInformatics research firm.
This award is one sign of how Dell’s focus on providing technology that will improve life sciences customers’ research efficiency and collaboration while lowering their cost of discovering new therapeutics is making an impact.
The cost of developing a new drug or medical device runs upwards of a million dollars a day and can take on average 17 years. Enabling customers to save even one day in this process translates into significant savings. Earlier today, Dell introduced a solution for an Electronic Lab Notebook, which combines servers and support with the Latitude XT tablets and Rescentris, Inc.’s Collaborative Electronic Research Framework (CERF), to create a system to manage research documents and make laboratory records and data available throughout R&D organizations. It’s important to us and that’s why we were the first company to integrate hardware, software and services to provide a solution designed to meet the needs of biotech and pharmaceutical companies ready to launch an ELN project.
By using an electronic lab notebook, researchers can capture all of their data electronically while experiments are happening. This capability allows scientists to share information across their organization, preventing repeats of the same experiments in different groups and driving better collaboration. Ultimately this can reduce the amount of time it takes to develop and bring a drug to market. The data is stored on a secure network rather than on the actual notebook, protecting the intellectual property and making it easier to store the data for long periods of time.
Have questions or thoughts about the ELN solution or Dell’s Health Care and Life Sciences business? Post them here.